Paper40939799
Functional antibacterial strategies of natural polysaccharides chitosan, hyaluronic acid, and alginate and their applications in tissue engineering: A review.
Ding X and 7 others. Int J Biol Macromol, 2025. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Functional antibacterial strategies of natural polysaccharides chitosan, hyaluronic acid, and alginate and their applications in tissue engineering: A review. Papers, record 40939799. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40939799
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Functional antibacterial strategies of natural polysaccharides chitosan, hyaluronic acid, and alginate and their applications in tissue engineering: A review.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chitosan | Major topic |
| Hyaluronic Acid | Major topic |
| Tissue Engineering | Major topic |
| Alginates | Major topic |
| Anti-Bacterial Agents | Major topic |
| Humans | |
| Animals | |
| Biocompatible Materials |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42857457 | Chitosan in regenerative medicine: a translational perspective on biomaterial design. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/42857457 | PubMed |
| 42371417 | Herbal polysaccharides-a rising star in engineering multifunctional biomaterials for tissue repair and regeneration. | Regen Biomater | 2026 | https://conductscience.org/library/papers/42371417 | PubMed |
| 42238322 | Functionalized polysaccharides for infection-resistant and regenerative therapies in gynecology. | Int J Pharm X | 2026 | https://conductscience.org/library/papers/42238322 | PubMed |
| 42074044 | Surface Characterization of DPPG Films Modified by Chitosan, Hyaluronic Acid and Titanium Dioxide. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074044 | PubMed |
| 41599249 | Innovative Titanium Implants Coated with miR-21-Loaded Nanoparticle for Peri-Implantitis Prevention. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41599249 | PubMed |
| 41583058 | Chitosan-based nanozyme hydrogels: Advanced antioxidant and sustained-release systems for the prevention and treatment of skin photoaging. | Int J Pharm X | 2026 | https://conductscience.org/library/papers/41583058 | PubMed |
| 41373700 | Antimicrobial Activity Versus Virulence Potential of Hyaluronic Acid: Balancing Advantages and Disadvantages. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373700 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40939799
GET https://conductscience.org/api/papers/v1/40939799/authors